SDGR - NASDAQ
Schrödinger, Inc.
$15.97
+6.9%Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
At a Glance
Live SnapshotSchrödinger, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Schrödinger, Inc. Cash Flow Statement
SDGR • NASDAQ
| Schrödinger, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||||||
-103.3M | -187.1M | 40.7M | -149.2M | -101.2M | -26.6M | -25.7M | -28.4M | -17.4M | |
6M | 6.2M | 5.6M | 4.3M | 2.8M | 3.7M | 3.6M | 2.9M | 1.7M | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -32.1M | -11.6M | 375K | -2.1M | |
43M | 49.9M | 47.8M | 39.6M | 26.5M | 10.5M | 2.2M | 1.3M | 888K | |
-50M | -13.3M | -208.3M | 6.9M | -3.5M | 2.1M | 1.1M | -149K | 19K | |
(0.0) | (1.1M) | (2.8M) | (787K) | (448K) | (381K) | (139K) | (13K) | (348K) | |
118.2M | -13M | -22.6M | -21.4M | 4.7M | 59.2M | 4.3M | 281K | 1.6M | |
13.9M | -157.4M | -136.7M | -119.7M | -70.7M | 16.8M | -26.1M | -23.7M | -15.3M | |
INVESTING ACTIVITIES | |||||||||
-1.4M | -7.3M | -13.4M | -8M | -7.2M | -2.5M | -1.8M | -5.3M | -3.7M | |
(0.0) | (45.7M) | -4.1M | -7M | (0.0) | -2.9M | (100K) | -3.6M | -600K | |
-313M | -251.3M | -320.6M | -271.5M | -418.5M | -519.7M | -110.2M | (3.6M) | -38.9M | |
372.3M | 361.8M | 384M | 364.7M | 408.5M | 138.8M | 57.2M | 20.1M | 42M | |
0.0 | 0.0 | 147.2M | 11.8M | 375K | 4.6M | 843K | -3.6M | 3.2M | |
(57.9M) | (148.8M) | (193M) | (90M) | -16.8M | -381.7M | -53.9M | (11.2M) | (2M) | |
FINANCING ACTIVITIES | |||||||||
3M | 8.9M | 0.0 | 0.0 | 0.0 | 537.1M | 0.0 | 896K | 1.1M | |
-58K | -58K | -19K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
0.0 | 1.3M | 9.1M | 2.1M | 8M | 4.2M | -1.2M | 80.3M | 0.0 | |
2.9M | 10.1M | 9M | 2.1M | 8M | 541.3M | 28.7M | 80.3M | 1.1M | |
CASH FLOW SUMMARY | |||||||||
74.7M | 1.6M | 65.3M | -27.6M | -79.5M | 176.3M | -51.2M | 67.8M | -12.1M | |
162.7M | 161.1M | 95.7M | 123.3M | 202.8M | 26.5M | 77.7M | 10M | 22.1M | |
237.4M | 162.7M | 161.1M | 95.7M | 123.3M | 202.8M | 26.5M | 77.7M | 10M | |
12.5M | -164.7M | -150.1M | -127.7M | -77.8M | 14.2M | -27.9M | -29M | -19M |
SEC Filings
SDGR - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 20, 2026 | May 18, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | April 28, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 12, 2026 | March 06, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 25, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 25, 2026 | February 25, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 05, 2025 | November 05, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 05, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | September 08, 2025 | September 05, 2025 | 2025 |
Related Guides
Continue your SDGR research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.